Future Genomics Technologies

Future Genomics Technologies is a specialized genomics contract research organization (CRO) leveraging cutting-edge next-generation sequencing (NGS) platforms, with a certified partnership with Oxford Nanopore Technologies. It offers a comprehensive suite of services, from complex de novo genome assembly and mRNA vaccine characterization to transgene analysis and contaminant identification, serving biopharma, agro-food, and academic sectors. Founded by experienced molecular biologists, the company operates as a technology integrator and service provider, bridging the gap between advanced genomic research and industrial application.

Integrated genomics service platform combining Oxford Nanopore Technologies (long-read) and Illumina (short-read) sequencing with proprietary bioinformatics pipelines for complex data analysis, de novo assembly, and specialized characterization.

FGT competes in the crowded genomics services market against large global CROs and academic core facilities. Its differentiation lies in deep expertise in complex, long-read-based applications and niche services like mRNA vaccine sequencing and transgene analysis, carving out a specialist position rather than competing on high-volume, low-cost sequencing.